RealClear Markets
Viewpoint: Failing RFK, Jr.’s science undermines U.S. innovation and opens the door to Chinese dominance
Since Dr. Vinay Prasad’s appointment as a key political voice within FDA, the tone of U.S. biotech policy has shifted from enabling ...